Brief: Ironwood Pharmaceuticals Satisfies Liquidity Conditions In Credit Agreement On March 10
11/03/2026 11:18
March 11 (Reuters) - Ironwood Pharmaceuticals Inc IRWD.O: IRONWOOD PHARMACEUTICALS INC - SATISFIES LIQUIDITY CONDITIONS IN CREDIT AGREEMENT ON MARCH 10, 2026 - SEC FILING IRONWOOD PHARMACEUTICALS INC - MATURITY DATE FOR REVOLVING CREDIT FACILITY REMAINS DECEMBER 31, 2028 - SEC FILING Further company coverage: IRWD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation